Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

Embody vs Fitstry

An in-depth comparison of two leading GLP-1 Providers

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
Embody logo

Embody

9.3
★★★★4.7/5

Best for: knowing which pharmacy fills the vial — it names RedRock Pharmacy

Visit Embody
VS
Fitstry logo

Fitstry

7.3
★★★3.7/5

Best for: compounded semaglutide at $169/month

Visit Fitstry

Two GLP-1 Providers chasing the same patients, trading off price, geography and what lands in the box differently. On our scoring, Embody opens cheaper — $79/mo against $169, and Embody finishes ahead, 9.3 to 7.3. What follows: the prices, what each plan actually covers, the six-dimension score, where each one is weak, and who should pick which.

Pricing

Embody

Injection — flat at every doseCompounded
$79/mo
semaglutide

Checkout: '$79/mo flat forever' (strikethrough $299); bundles $76/$73/$69 per month on 3/6/12-mo. CAVEAT: T&C list price is $199/mo — the $79 depends on the auto-applied SUMMER promo marketed as permanently locked; Trustpilot complaints allege the lock was not always honored.

Injection — flat at every doseCompounded
$129/mo
tirzepatide

Checkout tile 'Flat rate at $119/month (strikethrough $349)'; homepage 'starting at $129/month'; bundles $126/$123/$119 per month.

OralCompounded · oral
$229/mo
semaglutide

New oral semaglutide $229/mo.

Oral / gumCompounded · oral
$329/mo
tirzepatide

Oral tirzepatide $329/mo; gum bundles to $299/mo at 12-month.

Fitstry

Weekly injectionCompounded
$179/mo
semaglutide

Compounded semaglutide from $179/mo on the annual plan, or $249/mo month-to-month; the $99 program fee (refunded if not approved) applies before your first order.

Weekly injectionCompounded
$269/mo
tirzepatide

Compounded tirzepatide from $269/mo on the annual plan, or $339/mo month-to-month.

Daily oral tabletCompounded
$209/mo
GLP-1 (oral)

Daily oral GLP-1 tablets from $209/mo on the annual plan, or $279/mo month-to-month; the molecule isn't named publicly.

MicrodosingCompounded
$169/mo
semaglutide

Microdosing options start at $169/mo; the exact price and molecule are confirmed after the free screening.

What’s included

Embody

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

Not stated

Fitstry

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

Not stated

Score breakdown

Both providers are scored on the same six-dimension framework. The gradient bar marks the stronger side on each dimension.

Embody

9.3/10

Overall

Fitstry

7.3/10

Value25%

10.0A
vs
B
5.8

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

9.0A
vs
B
6.5

Accessibility10%

10.0A
vs
B
5.0

Support10%

7.0A
vs
B
7.0

Features & Coverage

FeatureEmbodyFitstry
Starting Price$79/mo$169/mo
Features6 features8 features
States Available50Not disclosed
Compounded✓ Yes✓ Yes
Brand Name
FSA/HSA Accepted
FDA WarningsNoneNone

About Embody

Embody sells compounded semaglutide and tirzepatide by injection, plus a compounded oral tirzepatide gum that is unique in the category. Flat-rate pricing is aggressive, coverage runs to all 50 states, and clinician messaging is available 24/7 under a board-certified internal medicine CMO.

Read our full Embody review →

About Fitstry

Nothing is paid at screening, which is free; the single program fee applies only to those who qualify, and it comes back if no clinician will prescribe. Discreet shipping, a Care Line staffed 24/7, coaching every two weeks, clinician access without limit and a lab panel are all wrapped into the monthly medication charge. Weightstry, LLC runs Fitstry for women 40+, cash-pay and LegitScript-certified, across 49 states, selling weekly injections of compounded tirzepatide and semaglutide, microdosing, and a GLP-1 tablet taken daily. Compounded medications lack FDA approval.

Read our full Fitstry review →

Pros & Cons

Embody

What we like

  • Semaglutide at $79 a month, 58% below the $189 median for the same drug and form across this register
  • Tirzepatide at $129 a month, 52% below the $267 median for the same drug and form across this register
  • Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
  • The monthly figure covers medication, consult, shipping
  • Coverage is published for all 50 states
  • Names 4 dispensing pharmacies, which most sellers in this register do not do
  • No FDA warning letter matched this operator when we searched our enforcement register
  • Both oral and injectable options are on record, so the format is a choice rather than a condition

Watch-outs

  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Fitstry

What we like

  • Semaglutide at $169 a month, within the normal band around this register's $189 median for the same drug and form
  • Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
  • The monthly figure covers medication, consult, shipping
  • No FDA warning letter matched this operator when we searched our enforcement register

Watch-outs

  • No state list is on record here, so whether it serves your state cannot be confirmed from this page
  • No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Our Verdict

Winner: Embody

Embody takes it, 9.3 against 7.3, and it is especially strong on knowing which pharmacy fills the vial — it names RedRock Pharmacy. Fitstry is no weak second and may fit you better on compounded semaglutide at $169/month.

Choose Embody if…

You want knowing which pharmacy fills the vial — it names RedRock Pharmacy and an opening price near $79 a month.

Choose Fitstry if…

You want compounded semaglutide at $169/month and an opening price near $169 a month.

Ready to start? Vetted GLP-1 providers

Vetted telehealth providers that prescribe GLP-1 online.

No insurance needed · vetted by our editors

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

7.0

MyDrHank

An oral route if you will not self-inject

6.0

SkinnyRx

Starting below a standard dose, with microdose tiers

9.4

Trimi Health

Knowing which pharmacy fills the vial — it names VialsRx

Embody vs Fitstry: FAQ

Glossary

The words sellers use, defined. Tap any term.

Continue exploring Embody and Fitstry head-to-heads in the same category.

Or see the full category ranking.

Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.